Total Payments
$817.61
2024 Payments
$125.14
Companies
14
Transactions
45
Medicare Patients
679
Medicare Billing
$77,982
Payment Breakdown by Category
Food & Beverage$779.05 (95.3%)
Other$38.56 (4.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $779.05 | 43 | 95.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $38.56 | 2 | 4.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $372.74 | 22 | $0 (2024) |
| Amgen Inc. | $117.93 | 5 | $0 (2020) |
| Eisai Inc. | $66.76 | 3 | $0 (2021) |
| Mallinckrodt Enterprises LLC | $46.64 | 3 | $0 (2019) |
| Mitsubishi Tanabe Pharma America, Inc. | $39.68 | 2 | $0 (2019) |
| Acorda Therapeutics, Inc | $38.56 | 2 | $0 (2019) |
| Amneal Pharmaceuticals LLC | $24.89 | 1 | $0 (2019) |
| Akcea Therapeutics, Inc. | $20.20 | 1 | $0 (2019) |
| Avanir Pharmaceuticals, Inc. | $18.29 | 1 | $0 (2019) |
| Vertical Pharmaceuticals, LLC | $16.41 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $125.14 | 7 | ABBVIE INC. ($125.14) |
| 2023 | $134.85 | 8 | AbbVie Inc. ($134.85) |
| 2022 | $35.08 | 2 | ABBVIE INC. ($35.08) |
| 2021 | $53.28 | 3 | AbbVie Inc. ($29.26) |
| 2020 | $128.17 | 6 | Amgen Inc. ($53.04) |
| 2019 | $341.09 | 19 | Amgen Inc. ($64.89) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/07/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: NEUROSCIENCE | ||||||
| 04/02/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: NEUROSCIENCE | ||||||
| 03/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/13/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: NEUROSCIENCE | ||||||
| 01/16/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: NEUROSCIENCE | ||||||
| 01/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/13/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/13/2023 | AbbVie Inc. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2023 | AbbVie Inc. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2023 | AbbVie Inc. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2023 | AbbVie Inc. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2023 | AbbVie Inc. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/05/2023 | AbbVie Inc. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: NEUROSCIENCE | ||||||
| 07/07/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: SPASTICITY | ||||||
| 06/02/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: SPASTICITY | ||||||
| 11/11/2021 | AbbVie Inc. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: NEUROSCIENCE | ||||||
| 06/30/2021 | AbbVie Inc. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: NEUROSCIENCE | ||||||
| 04/22/2021 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $24.02 | General |
| Category: Neurology | ||||||
| 11/20/2020 | AbbVie Inc. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: NEUROSCIENCE | ||||||
| 03/06/2020 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $21.37 | General |
| Category: Neurology | ||||||
| 02/25/2020 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Neuroscience | ||||||
| 01/31/2020 | Eisai Inc. | Fycompa (Drug) | Food and Beverage | Cash or cash equivalent | $21.37 | General |
| Category: Neurology | ||||||
| 01/24/2020 | Vertical Pharmaceuticals, LLC | LORZONE (Drug), RELEXXII, DIVIGEL | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: MUSCLE RELAXANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 545 | 664 | $383,005 | $60,993 |
| 2022 | 5 | 134 | 179 | $107,781 | $16,990 |
Total Patients
679
Total Services
843
Medicare Billing
$77,982
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 132 | 134 | $128,640 | $18,224 | 14.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 158 | 234 | $81,198 | $14,641 | 18.0% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 43 | 77 | $76,939 | $12,343 | 16.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 47 | 52 | $25,792 | $4,894 | 19.0% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2023 | 33 | 34 | $22,304 | $3,539 | 15.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 50 | 50 | $13,950 | $2,200 | 15.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 20 | $13,892 | $1,978 | 14.2% |
| 95813 | Measurement of brain wave activity (eeg), 61-119 minutes | Facility | 2023 | 19 | 19 | $7,980 | $1,245 | 15.6% |
| 95822 | Measurement of brain wave activity (eeg), in coma or asleep | Facility | 2023 | 17 | 17 | $4,777 | $747.79 | 15.7% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Facility | 2023 | 15 | 15 | $4,185 | $654.25 | 15.6% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 12 | 12 | $3,348 | $525.64 | 15.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 35 | 36 | $34,560 | $5,607 | 16.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 52 | 83 | $28,801 | $4,650 | 16.1% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 11 | 16 | $15,952 | $2,626 | 16.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 22 | 22 | $17,556 | $2,335 | 13.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 22 | $10,912 | $1,772 | 16.2% |
About Lionel Thomas
Lionel Thomas is a Neurology healthcare provider based in Parker, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/29/2016. The National Provider Identifier (NPI) number assigned to this provider is 1225483035.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lionel Thomas has received a total of $817.61 in payments from pharmaceutical and medical device companies, with $125.14 received in 2024. These payments were reported across 45 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($779.05).
As a Medicare-enrolled provider, Thomas has provided services to 679 Medicare beneficiaries, totaling 843 services with total Medicare billing of $77,982. Data is available for 2 years (2022–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology, Epilepsy
- Location Parker, CO
- Active Since 04/29/2016
- Last Updated 11/10/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1225483035
Products in Payments
- DUOPA (Drug) $233.05
- Aimovig (Biological) $117.93
- BOTOX (Biological) $107.26
- Fycompa (Drug) $66.76
- ACTHAR (Biological) $46.64
- Radicava (Drug) $39.68
- INBRIJA (Drug) $38.56
- Duopa (Drug) $32.43
- RYTARY (Drug) $24.89
- TEGSEDI (Drug) $20.20
- NUEDEXTA (Drug) $18.29
- LORZONE (Drug) $16.41
- GOCOVRI (Drug) $15.62
- INGREZZA (Drug) $15.01
- NORTHERA (Drug) $12.67
- Lioresal (baclofen) (Drug) $12.21
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.